Evidence map›Paper›PMID 37960239›Full record

Trial reportNutrients2023

Neuroimaging Insights: Kava's (

Karen Savage, Jerome Sarris, Matthew Hughes, Chad A Bousman, Susan Rossell, Andrew Scholey, Con Stough, Chao Suo

Abstract readRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Nutrients, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Karen SavageCentre for Human Psychopharmacology, Swinburne University of Technology, 427-451 Burwood Road, Melbourne 3122, Australia.ORCID 0000-0002-8075-9222
Jerome SarrisFlorey Institute of Neuroscience and Mental Health, Melbourne University, Melbourne 3121, Australia.
Matthew HughesCentre for Mental Health, Swinburne University of Technology, Melbourne 3122, Australia.
Chad A BousmanDepartments of Medical Genetics, Psychiatry, Physiology & Pharmacology, and Community Health Sciences, University of Calgary, Calgary, AB T2N 1N4, Canada.ORCID 0000-0001-6303-8696
Susan RossellCentre for Mental Health, Swinburne University of Technology, Melbourne 3122, Australia.
Andrew ScholeyCentre for Human Psychopharmacology, Swinburne University of Technology, 427-451 Burwood Road, Melbourne 3122, Australia.ORCID 0000-0003-4484-5462
Con StoughCentre for Human Psychopharmacology, Swinburne University of Technology, 427-451 Burwood Road, Melbourne 3122, Australia.ORCID 0000-0002-3628-3220
Chao SuoBrain Park, Turner Institute of Brain and Mind, Monash University, Melbourne 3800, Australia.

Funding

National Health and Medical Research Council APP1063383
6 · The paper itself

Abstract

Generalised Anxiety Disorder (GAD) is a prevalent, chronic mental health disorder. The measurement of regional brain gamma-aminobutyric acid (GABA) offers insight into its role in anxiety and is a potential biomarker for treatment response. Research literature suggests

Indexed as

Anti-Anxiety AgentsKavaAdultAnxiety DisordersBiomarkersGyrus CinguliHumansNeuroimagingPhytotherapyPlant ExtractsAnti-Anxiety AgentsBiomarkersPlant Extractsanterior cingulateGABAgeneralised anxiety disorderkavamagnetic resonance spectroscopy

Identifiers

PMID37960239
PMCPMC10649338

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.